Clinical trial

Prevention of AIDS With Opportunistic Infection Paradoxical IRIS

NCT07565623

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-05-01

PhaseNA

Study timeline

Study start (estimated)2026-05-01Date precision: day

Registry last updated2026-05-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV (Human Immunodeficiency Virus)unresolved

IRISunresolved

Interventions

PrednisoloneDRUG · verified · RxNorm: prednisolone

Sponsors & collaborators

Shanghai Public Health Clinical Centerlead sponsor

Beijing Ditan Hospitalcollaborator

Meng Chao Hepatobiliary Hospital of Fujian Medical Universitycollaborator

Chengdu Public Health Clinical Centercollaborator

The Third Affiliated Hospital of Kunming Medical College.collaborator

Chongqing Public Health Medical Centercollaborator

The Second Hospital of Nanjing Medical Universitycollaborator

First Affiliated Hospital of Zhejiang Universitycollaborator

Peking Union Medical College Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07565623 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.